Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.736
+0.104 (16.51%)
Mar 9, 2026, 3:23 PM EDT - Market open
Werewolf Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | - | 1.89 | 19.94 | 16.4 | - | - | Upgrade
|
| Revenue Growth (YoY) | - | -90.55% | 21.60% | - | - | - | Upgrade
|
| Cost of Revenue | 50.48 | 53.09 | 38.91 | 50.96 | 33.98 | - | Upgrade
|
| Gross Profit | -50.48 | -51.2 | -18.96 | -34.56 | -33.98 | - | Upgrade
|
| Selling, General & Admin | 21.13 | 22.39 | 21.54 | 21.5 | 16.11 | 5.76 | Upgrade
|
| Research & Development | - | - | - | - | - | 16.64 | Upgrade
|
| Operating Expenses | 21.13 | 22.39 | 21.54 | 21.5 | 16.11 | 22.4 | Upgrade
|
| Operating Income | -71.61 | -73.59 | -40.5 | -56.06 | -50.09 | -22.4 | Upgrade
|
| Interest Expense | -5.17 | -4.66 | -3.14 | - | - | - | Upgrade
|
| Interest & Investment Income | 3.85 | 6.67 | 7.42 | 1.91 | 0.1 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.09 | 1.62 | -1.14 | 0.34 | - | 7.3 | Upgrade
|
| EBT Excluding Unusual Items | -72.84 | -69.96 | -37.37 | -53.81 | -49.98 | -15.04 | Upgrade
|
| Other Unusual Items | - | -0.55 | - | - | - | - | Upgrade
|
| Pretax Income | -72.84 | -70.52 | -37.37 | -53.81 | -49.98 | -15.04 | Upgrade
|
| Net Income | -72.84 | -70.52 | -37.37 | -53.81 | -49.98 | -15.04 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 151.94 | 13.18 | Upgrade
|
| Net Income to Common | -72.84 | -70.52 | -37.37 | -53.81 | -201.93 | -28.22 | Upgrade
|
| Shares Outstanding (Basic) | 45 | 43 | 36 | 29 | 18 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 44 | 36 | 29 | 18 | 1 | Upgrade
|
| Shares Change (YoY) | 8.88% | 23.04% | 23.50% | 56.40% | 1736.32% | 57.27% | Upgrade
|
| EPS (Basic) | -1.62 | -1.63 | -1.05 | -1.86 | -10.94 | -28.08 | Upgrade
|
| EPS (Diluted) | -1.62 | -1.63 | -1.05 | -1.86 | -10.94 | -28.08 | Upgrade
|
| Free Cash Flow | -63.64 | -56.44 | -33.38 | -44.21 | -43.37 | -19.18 | Upgrade
|
| Free Cash Flow Per Share | -1.41 | -1.29 | -0.94 | -1.53 | -2.35 | -19.09 | Upgrade
|
| Gross Margin | - | - | -95.09% | -210.69% | - | - | Upgrade
|
| Operating Margin | - | -3904.19% | -203.09% | -341.78% | - | - | Upgrade
|
| Profit Margin | - | -3740.85% | -187.37% | -328.09% | - | - | Upgrade
|
| Free Cash Flow Margin | - | -2994.27% | -167.38% | -269.54% | - | - | Upgrade
|
| EBITDA | -69.93 | -71.78 | -38.74 | -54.95 | -49.87 | -22.25 | Upgrade
|
| EBITDA Margin | - | - | -194.25% | - | - | - | Upgrade
|
| D&A For EBITDA | 1.68 | 1.81 | 1.76 | 1.1 | 0.22 | 0.15 | Upgrade
|
| EBIT | -71.61 | -73.59 | -40.5 | -56.06 | -50.09 | -22.4 | Upgrade
|
| EBIT Margin | - | - | -203.09% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.